GenoLogics is working with the Ontario Cancer Biomarker Network (OCBN) to deploy its lab and proteomics data management system. The OCBN offers biomarker research services and solutions to academic and industrial researchers. The network, which includes several proteomics service labs in Ontario, is expanding its infrastructure to ensure that different disciplines, technologies and expertise operate seamlessly across multiple facilities to meet the needs of the biomarker research community, irrespective of the size and scale of research projects.
Ken Evans, CEO for the Ontario Cancer Biomarker Network, said: 'The Proteus system enables our integrative proteomics approach across multiple labs by automating mass spectrometry data processing workflows and centralising data and project management.'
Proteus combines the strength of a robust multi-lab platform while maintaining its ability to be configured for the proteomics research being conducted in each lab. It improves lab efficiency by automating data capture from mass spectrometry instruments and protein search engines, and by seamlessly tracking projects, samples and results. As a ready-to-use solution, Proteus can be quickly deployed, while also being easily adapted for future integrations to facilitate standardised data processing and bioinformatics pipelines.
